Potential antitumor agents. Derivatives of 2-hydrazino-5-nitropyridine.
D000230:Adenocarcinoma / Q000188:drug therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D055598:Chemical Phenomena; D002621:Chemistry; D006834:Hydrazines / Q000138:chemical synthesis / Q000627:therapeutic use / Q000633:toxicity; D007939:Leukemia L1210 / Q000188:drug therapy; D009374:Neoplasms, Experimental / Q000188:drug therapy*; D011725:Pyridines / Q000138:chemical synthesis / Q000627:therapeutic use* / Q000633:toxicity; D051381:Rats; D012510:Sarcoma 180 / Q000188:drug therapy
D000970:Antineoplastic Agents; D006834:Hydrazines; D011725:Pyridines